Which patients would you treat with relugolix instead of injectable GnRH agonist therapy?
HERO study - https://clinicaltrials.gov/ct2/show/NCT03085095
Answer from: Medical Oncologist at Academic Institution
I would consider relugolix for patients with: 1. Intermediate-risk prostate cancer that needs a short course of androgen deprivation therapy 2. Patients with biochemical relapse that would benefit from a short course of ADT and salvage RT2.5 Patient with pre-existing cardiac comorbidities&...
Sign in or Register to read more